Ace-ER regulatory update

Ultragenyx withdrew an MAA from EMA for aceneuramic acid prolonged release (Ace-ER) seeking conditional approval to treat GNE myopathy (NGEM)/hereditary inclusion body myopathy (HIBM) in adults. The c...